Therapeutic strategy for in-stent restenosis based on the restenosis pattern after drug-eluting stent implantation

Korean Circulation Journal

Volumn 39, Issue 10, 2009, Pages 408-413

  Kim, Ki Hun ^a   Kim, Doo Il ^a   Kim, Il Hwan ^a   Kim, Jong Yoon ^a   Han, Yang Chun ^a   Seol, Sang Hoon ^a   Ung, Kim ^a   Yang, Tae Hyun ^a   Kim, Dae Kyeong ^a   Kim, Dong Soo ^a   Lee, Sang Hee ^b   Park, Jong Seon ^b   Kim, Young Jo ^b   Shin, Dong Gu ^b   Cho, Yoon Kyung ^c   Nam, Chang Wook ^c   Hur, Seung Ho ^c   Kim, Kwon Bae ^c  

^a Inje University College of Medicine   (South Korea)

^b Yeungnam University College of Medicine   (South Korea)

^c Keimyung University   (South Korea)

Author keywords

Coronary restenosis; Drug eluting stent; Percutaneous transluminal coronary angioplasty; Restenosis

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REPEAT PROCEDURE; RESTENOSIS; SILENT MYOCARDIAL ISCHEMIA; STABLE ANGINA PECTORIS; TREATMENT FAILURE; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 70449555295     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2009.39.10.408     Document Type: Article

References (22)

1. Costa MA, Simon DI. Molecular basis of restenosis and drug-eluting stents. Circulation 2005; 111: 2257-2273 (Pubitemid 40632443)
2. Costa MA. Treatment of drug-eluting stent restenosis. Am Heart J 2007; 153: 447-449
3. Solinas E, Dangas G, Kirtane AJ, et al. Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention. Am J Cardiol 2008; 102: 311-315
4. Kim YH, Lee BK, Park DW, et al. Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis. Am J Cardiol 2006; 98: 1451-1454
5. Steinberg DH, Pinto Slottow TL, Buch AN, et al. Impact of in-stent restenosis on death and myocardial infarction. Am J Cardiol 2007; 100: 1109-1113 (Pubitemid 47404468)
6. Lee SR, Jeong MH, Lim SY, et al. Comparison of the clinical effect of cutting balloon angioplasty and drug-eluting stent for treating the focal type of in-stent restenosis. Korean Circ J 2006; 36: 279-284
7. Cosgrave J, Melzi G, Corbett S, et al. Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent. Am Heart J 2007; 153: 354-359 (Pubitemid 46328767)
8. Moussa ID, Moses JW, Kuntz RE, et al. The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial). Am J Cardiol 2006; 97: 1582-1584
9. Airoldi F, Briguori C, Iakovou I, et al. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis. Am J Cardiol 2006; 97: 1182-1187
10. Lee HG, Chun KJ, Cho KI, et al. Impact of drug-eluting stents on clinical outcomes in patients with diffuse coronary lesions. Korean Circ J 2008; 38: 612-617
11. Cosgrave J, Melzi G, Biondi-Zoccai GG, et al. Drug-eluting stent restenosis the pattern predicts the outcome. J Am Coll Cardiol 2006; 47: 2399-2404 (Pubitemid 43866381)
12. Sukhija R, Aronow WS, Sureddi R, et al. Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus. Am J Cardiol 2007; 100: 777-780 (Pubitemid 47268266)
13. Eisenberg MJ, Konnyu KJ. Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis. Am J Cardiol 2006; 98: 375-382 (Pubitemid 44062448)
14. Mitra AK, Agrawal DK. In stent restenosis: bane of the stent era. J Clin Pathol 2006; 59: 232-239
15. Yang TH, Kim DI, Park SG, et al. Clinical characteristics of stent fracture after sirolimus-eluting stent implantation. Int J Cardiol 2009; 131: 212-216
16. Aoki J, Nakazawa G, Tanabe K, et al. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv 2007; 69: 380-386 (Pubitemid 46339279)
17. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999; 100: 1872-1878 (Pubitemid 29511140)
18. Albiero R, Silber S, Di Mario C, et al. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT). J Am Coll Cardiol 2004; 43: 943-949 (Pubitemid 38352970)
19. Airoldi F, Rogacka R, Briguori C, et al. Comparison of clinical and angiographic outcome of sirolimus-eluting stent implantation versus cutting balloon angioplasty for coronary in-stent restenosis. Am J Cardiol 2004; 94: 1297-1300 (Pubitemid 39469954)
20. Liistro F, Fineschi M, Angioli P, et al. Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: the TRUE (Tuscany Registry of Sirolimus for Unselected In-Stent Restenosis) Registry. J Am Coll Cardiol 2006; 48: 270-275
21. Alfonso F, Perez-Vizcayno MJ, Hernandez R, et al. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol 2006; 47: 2152-2160 (Pubitemid 43795079)
22. Kastrati A, Mehilli J, von Beckerath N, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005; 293: 165-171 (Pubitemid 40095867)